Copyright © Philip M. Parker, INSEAD. Terms of Use.

BRL 26830A

Specialty Definition: BRL 26830A

DomainDefinition

Health

An atypical B adrenoreceptor agonist drug that in obese rodents showed an increased metabolic rate and caused a reduction in weight by decreasing body lipid content. It is not approved as a weight loss drug by FDA. (references)

Source: compiled by the editor from various references; see credits.

Top     

Alternative Orthography: BRL 26830A


Hexadecimal (or equivalents, 770AD-1900s) (references)

42 52 4C      32 36 38 33 30 41

Leonardo da Vinci (1452-1519; backwards) (references)

    

Binary Code (1918-1938, probably earlier) (references)

01000010 01010010 01001100 00100000 00110010 00110110 00111000 00110011 00110000 01000001

HTML Code (1990) (references)

&#66 &#82 &#76 &#32 &#50 &#54 &#56 &#51 &#48 &#65

ISO 10646 (1991-1993) (references)

0042 0052 004C      0032 0036 0038 0033 0030 0041

Encryption (beginner's substitution cypher): (references)

3652462202426211835

Top     



INDEX

1. Orthography
2. Bibliography


  

Copyright © Philip M. Parker, INSEAD. Terms of Use.